Phillips, Andrew, Venter, Francois, Havlir, Diana et al. (21 more authors) (2018) Risks and benefits for use of dolutegravir-based antiretroviral drug regimens in sub Saharan Africa: a modelling study. The Lancet HIV. pp. 1-12. ISSN 2352-3018
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2018 The Author(s). Published by Elsevier Ltd. |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York) |
Depositing User: | Pure (York) |
Date Deposited: | 10 Dec 2018 15:10 |
Last Modified: | 24 Oct 2024 00:05 |
Published Version: | https://doi.org/10.1016/S2352-3018(18)30317-5 |
Status: | Published online |
Refereed: | Yes |
Identification Number: | 10.1016/S2352-3018(18)30317-5 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:139791 |
Downloads
Filename: regimen_ms_final_accepted_lancet_hiv_7_nov_2018.docx
Description: regimen ms - final accepted lancet hiv - 7 nov 2018
Licence: CC-BY-NC-ND 2.5
Filename: 1_s2.0_S2352301818303175_main.pdf
Description: 1-s2.0-S2352301818303175-main
Licence: CC-BY-NC-ND 2.5